
Veeva Systems Inc. (VEEV)
$
172.59
-5.69 (-3.30%)
Key metrics
Financial statements
Free cash flow per share
8.4560
Market cap
28.4 Billion
Price to sales ratio
8.8788
Debt to equity
0.0133
Current ratio
4.8854
Income quality
1.5571
Average inventory
0
ROE
0.1341
Technology
Technology – consumer electronics
Largecap
With a market cap of 121,78 bil stock is ranked 1
Low risk
ISS score of this stock is ranked 1
Company description
Profile
Veeva Systems Inc. delivers cloud-based software solutions tailored for the life sciences sector across North America, Europe, the Asia Pacific, the Middle East, Africa, and Latin America. The company reported depreciation and amortization expenses of $0.00 reflecting the wear and tear of its assets. Furthermore, it earned an interest income of $0.00 showcasing its financial investments. The EBITDA is $916,369,000.00 a key indicator of the company's operational profitability, and all financial data pertains to the fiscal year 2026. Additionally, the company incurred an interest expense of $0.00 reflecting its debt servicing obligations. Veeva offers a comprehensive Veeva Commercial Cloud suite, which encompasses a variety of software, data, and analytics solutions like Veeva customer relationship management (CRM) and Veeva Medical CRM, alongside tools such as Veeva CLM, Veeva CRM MyInsights, Veeva CRM Approved Email, Veeva CRM Engage, and Veeva Align, among others. It also provides Veeva Vault for enterprise content and data management, facilitating the management of commercial functions including sales, marketing, medical communications, and research areas such as clinical, regulatory, quality, and safety processes. The company supports clients with professional services that encompass implementation planning, project management, solution design, systems integration, and ongoing managed services, which include outsourced administration. The stock is priced at $277.79 positioning it in the higher-end market, and it boasts a high average trading volume of 2,102,725.00 indicating strong liquidity. With a mid-range market capitalization of $28,370,663,492.00 the company is a steady performer in its field. As a key player in the Medical - Healthcare Information Services industry, Veeva Systems contributes significantly to the overall market landscape and belongs to the Healthcare sector, driving innovation and growth. The diverse range of solutions offered underscores its commitment to advancing the life sciences field, making it an essential partner for organizations aiming to enhance their operational efficiencies and deliver impactful results. Veeva Systems Inc., formerly known as Verticals onDemand, Inc., has established itself since its incorporation in 2007 and continues to thrive with its headquarters in Pleasanton, California.
Investing in Veeva Systems Inc. (VEEV) depends on multiple factors, including revenue growth, profit margins, debt-to-equity ratio, earnings per share, and return on equity. Analysts have rated it as A-, with a Bearish outlook. Always conduct your own research before investing.
Analysts predict Veeva Systems Inc. stock to fluctuate between $168.14 (low) and $310.50 (high) in the next 365 days, reflecting market expectations and potential volatility.
As of 2026-03-27, Veeva Systems Inc.'s market cap is $28,370,663,492, based on 164,381,850 outstanding shares.
Compared to Nvidia Corp, Veeva Systems Inc. has a Lower Market-Cap, indicating a difference in performance.
To buy Veeva Systems Inc. (VEEV) stock: Open a brokerage account (e.g., Robinhood, TD Ameritrade, E-Trade). Search for VEEV. Place an order (Market, Limit, etc.).
The best time to invest depends on market trends and technical indicators, which show a Bearish trend based on economic conditions and company performance.
Revenue: $3,195,311,000 | EPS: $5.55 | Growth: 25.85%.
Visit https://www.veeva.com/investor-relations for detailed financial reports.
You can explore historical data from here
All-time high: $343.96 (2021-08-05) | All-time low: $151.02 (2022-10-14).
Key trends include market demand, economic conditions, interest rates, and industry competition, which influence the stock's performance.
News

zacks.com
After reaching an important support level, Veeva Systems (VEEV) could be a good stock pick from a technical perspective. VEEV surpassed resistance at the 20-day moving average, suggesting a short-term bullish trend.

zacks.com
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

fool.com
Veeva Systems has produced solid returns since it became public. The company is facing some challenges, notably increased competition.

zacks.com
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

prnewswire.com
/PRNewswire/ -- Veeva Systems (NYSE: VEEV) gab heute bekannt, dass AOP Health, ein international führender Anbieter von integrierten Therapien für seltene

prnewswire.com
PLEASANTON, Calif., March 10, 2026 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced the acquisition of Ostro, the leading brand engagement platform for life sciences that gives patients and doctors immediate, compliant answers through an easy-to-use AI-driven chat experience.

zacks.com
VEEV beats Q4 estimates with 16% revenue growth and strong subscription demand, while an upbeat FY27 outlook and expanding AI capabilities push shares higher.

benzinga.com
On Wednesday, Veeva Systems Inc. (NYSE: VEEV) reported fourth-quarter fiscal 2026 financial results and provided guidance.

seekingalpha.com
I maintain my “hold” rating on Veeva Systems due to decelerating revenue growth and margin contraction projection in FY27 despite a recent Q4 earnings beat. FY27 guidance shows revenue growth slowing to 13% and margins contracting by 100 bps, as management projects that building industry-specific AI in Life Sciences could be time-consuming. Uncertainty surrounds the monetization timeline for Veeva AI, even though management points out that their system of record won't be disrupted by Agentic AI.

seekingalpha.com
Veeva Systems delivered a double beat in FY26, surpassing revenue guidance with 16% Y/Y growth and strong Q1/27 guidance. AI disruption fears are overblown for VEEV; its regulatory moat, proprietary data, and mission-critical workflows provide durable competitive advantages. VEEV trades at a 47x P/E, slightly overvalued; a 40x multiple would offer a more attractive risk/reward for long-term investors.
See all news